Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04402086
Other study ID # 2000026608
Secondary ID No NIH funding
Status Recruiting
Phase
First received
Last updated
Start date August 4, 2020
Est. completion date June 1, 2030

Study information

Verified date December 2023
Source Yale University
Contact Nicolas Page
Phone 203-737-5571
Email scleroderma@yale.edu
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.


Description:

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date June 1, 2030
Est. primary completion date June 1, 2030
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria for Rheumatology Patients: - Patients =18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis. - Receiving clinical care at Yale Rheumatology clinics Exclusion Criteria for Rheumatology Patients: - Unable to provide informed consent - No patients will be excluded based on gender or ethnicity or pregnancy status. - Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver. - Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy. Inclusion Criteria for Healthy Volunteers: - Age = 18 years old - No chronic skin conditions - No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis) - Normal BMI Exclusion Criteria for Healthy Volunteers: - Unable to provide informed consent. - Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman. - Allergies to lidocaine or epinephrine (skin biopsies). - A history of impaired wound healing (skin biopsies).

Study Design


Related Conditions & MeSH terms

  • Adult Onset Still Disease
  • Ankylosing Spondylitis
  • Antiphospholipid Syndrome
  • Arteritis
  • Arthritis
  • Arthritis, Psoriatic
  • Arthritis, Reactive
  • Behcet Disease
  • Behcet Syndrome
  • Collagen Diseases
  • Connective Tissue Diseases
  • Dermatomyositis
  • Giant Cell Arteritis
  • Lupus Erythematosus, Systemic
  • Lyme Disease
  • Mixed Connective Tissue Disease
  • Polymyalgia Rheumatica
  • Polymyositis
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Rheumatic Diseases
  • Rheumatoid Arthritis
  • Sarcoidosis
  • Scleroderma
  • Scleroderma, Systemic
  • Sjogren's Syndrome
  • Spondylitis
  • Spondylitis, Ankylosing
  • Still's Disease, Adult-Onset
  • Syndrome
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Undifferentiated Connective Tissue Diseases

Locations

Country Name City State
United States Yale New Haven Hospital New Haven Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Yale University Rheumatology Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlate outcomes and biomarkers of rheumatic diseases Evaluate clinical data and biospecimens to correlate outcomes and biomarkers of rheumatic diseases. 10 years
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4